Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review

Temozolomide (TMZ) is an alkylating chemotherapeutic agent that has recently been used in some cases as a new therapeutic tool for pituitary carcinomas and aggressive pituitary adenomas. In this report, we present the case of effective TMZ treatment in a 42-year-old man with ACTH-secreting carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtò, Lorenzo, Torre, Maria L., Ferraù, Francesco, Pitini, Vincenzo, Altavilla, Giuseppe, Granata, Francesca, Longo, Marcello, Hofland, Leo J., Trimarchi, Francesco, Cannavò, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2010
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763678/
https://www.ncbi.nlm.nih.gov/pubmed/21057727
http://dx.doi.org/10.1100/tsw.2010.210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763678/
https://www.ncbi.nlm.nih.gov/pubmed/21057727
http://dx.doi.org/10.1100/tsw.2010.210

Ejemplares similares